Ascendis Pharma A/S
ASND | NASDAQ
$250.71
-$0.56 (-0.22%)
Nov 2, 2026, 3:42 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.05B | 867.51M | 717.81M | 646.55M | 490.75M | 368.7M | 363.64M | 327.43M | 317.63M | 329.02M | 266.72M | 151.91M | 119.17M | 77.94M | 51.17M | 33.18M | 19M | 13.86M | 7.78M | 3.42M | 5.06M | 5.47M |
Cost of Revenue | 103.47M | 102.62M | 98.52M | 85.34M | 74.19M | 54.21M | 44.26M | 49.69M | 45.88M | 47.34M | 44.4M | 30.05M | 24.36M | 12.51M | 12.14M | 10.55M | 8.86M | 7.77M | 3.52M | 185.15M | 249.21M | 312.79M |
Gross Profit | 950.9M | 764.89M | 619.3M | 561.21M | 416.56M | 314.5M | 319.38M | 277.74M | 271.75M | 281.68M | 222.32M | 121.86M | 94.81M | 65.42M | 39.04M | 22.63M | 10.14M | 6.09M | 4.26M | -181.74M | -244.15M | -307.32M |
Operating Income | 109.45M | -6.93M | -136.36M | -145.78M | -253.52M | -333.83M | -278.76M | -315.76M | -353.42M | -361M | -455.54M | -566.32M | -576.41M | -577.47M | -561.81M | -527.01M | -479.44M | -455.17M | -451.79M | -434.85M | -416.75M | -382.07M |
Interest Income | 52.04M | 86.8M | 111.06M | 20.69M | 45.65M | 39.64M | 14.36M | 80.91M | 56.77M | 43.48M | 85.04M | 85.04M | 101.22M | 136.59M | 104.5M | 104.5M | 105.49M | 34.51M | 55.9M | 56.03M | 34.84M | 34.78M |
Pretax Income | 101.11M | -167.8M | -212.4M | -223.33M | -264.13M | -338.28M | -373.24M | -416.94M | -480.34M | -493.06M | -474.15M | -595.13M | -602.67M | -562.17M | -577.81M | -481.92M | -393.14M | -446.22M | -383.94M | -416.75M | -458.17M | -418.76M |
Net Income | 755.85M | 506.6M | -227.72M | -232.94M | -271.15M | -341.67M | -378.08M | -426.49M | -489.52M | -501.57M | -481.45M | -601.99M | -608.72M | -568.61M | -583.19M | -481.83M | -393.23M | -446.28M | -383.58M | -416.48M | -457.87M | -418.43M |
Selling & General & Admin | 565.59M | 496.78M | 446.25M | 391.83M | 348.27M | 316.87M | 288.01M | 273.2M | 267.58M | 263.55M | 263.31M | 255.89M | 254.04M | 240.35M | 221.23M | 212.98M | 191.59M | 170.35M | 160.18M | 132.3M | 110.54M | 96M |
Research & Development | 274.14M | 271.47M | 300.45M | 304.77M | 311.43M | 322.92M | 307.01M | 318.59M | 356.49M | 378.03M | 413.46M | 431.19M | 417.18M | 402.55M | 379.63M | 336.66M | 297.99M | 290.91M | 295.87M | 305.97M | 311.27M | 291.54M |
Other Expenses | 1.72M | 3.57M | 8.97M | 10.4M | 10.38M | 8.53M | 3.14M | 1.7M | 1.1M | 1.1M | 1.1M | 1.1M | n/a | n/a | n/a | n/a | n/a | n/a | 0 | -185.15M | -249.21M | -312.79M |
Operating Expenses | 841.45M | 771.82M | 755.66M | 706.99M | 670.08M | 648.32M | 598.15M | 593.49M | 625.17M | 642.68M | 677.86M | 688.18M | 671.23M | 642.89M | 600.85M | 549.64M | 489.58M | 461.26M | 456.05M | 253.12M | 172.6M | 74.75M |
Interest Expense | 163.89M | 182.5M | 158.92M | 40.9M | 46.52M | 33.13M | 65.5M | 190.69M | 189.86M | 179.57M | 112.25M | 115.37M | 132.09M | 132.19M | 127.75M | 101.31M | 60.94M | 63.65M | 59.12M | 53.25M | 92.35M | 90.5M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 2.02M | 2.02M | 2.02M | 2.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 944.92M | 874.45M | 854.17M | 792.33M | 744.27M | 702.53M | 642.4M | 643.18M | 671.05M | 690.02M | 722.26M | 718.23M | 695.58M | 655.4M | 612.99M | 560.18M | 498.43M | 469.03M | 459.57M | 438.27M | 421.81M | 387.54M |
Income Tax Expense | -654.74M | -674.4M | 15.32M | 9.61M | 7.01M | 3.4M | 4.84M | 9.55M | 9.17M | 8.51M | 7.3M | 6.86M | 6.05M | 6.43M | 5.38M | -87K | 85K | 64K | -368K | -271K | -295K | -333K |
Shares Outstanding (Basic) | 64.34M | 61.68M | 61.38M | 60.99M | 60.45M | 60.02M | 59.79M | 58.57M | 57.35M | 56.88M | 56.61M | 56.27M | 56.22M | 56.09M | 55.99M | 55.83M | 55.81M | 56.72M | 53.85M | 54.64M | 53.85M | 53.76M |
Shares Outstanding (Diluted) | 68.32M | 64.52M | 61.38M | 60.99M | 63.91M | 60.02M | 59.79M | 58.57M | 57.35M | 56.88M | 56.61M | 56.27M | 56.22M | 56.09M | 55.99M | 55.83M | 55.81M | 56.72M | 53.85M | 54.64M | 53.85M | 53.76M |
EPS (Basic) | 12.10 | 8.19 | -3.76 | -3.86 | -4.55 | -5.82 | -6.54 | -7.43 | -8.62 | -8.87 | -8.55 | -10.72 | -10.87 | -10.17 | -10.40 | -8.67 | -7.11 | -8.15 | -7.11 | -7.74 | -8.58 | -8.05 |
EPS (Diluted) | 11.45 | 7.55 | -3.94 | -4.04 | -4.73 | -5.82 | -6.54 | -7.43 | -8.62 | -8.87 | -8.55 | -10.72 | -10.87 | -10.17 | -10.40 | -8.67 | -7.11 | -8.15 | -7.11 | -7.72 | -8.56 | -8.03 |
EBITDA | 78.13M | 12.37M | -55.55M | -133.16M | -150.94M | -240.77M | -243.42M | -273.21M | -334.4M | -354.77M | -411.17M | -472.44M | -463.36M | -422.95M | -435.11M | -406.72M | -359.17M | -410.38M | -353.34M | -427.23M | -431.07M | -394.94M |
EBIT | 60.4M | -5.03M | -73.2M | -150.51M | -165.97M | -253.51M | -256.09M | -286.39M | -350.62M | -373.62M | -430.08M | -487.81M | -478.63M | -438.03M | -450.06M | -424.51M | -376.1M | -426.47M | -368.73M | -441.34M | -443.66M | -406.11M |
Depreciation & Amortization | 17.73M | 17.4M | 17.65M | 17.35M | 15.03M | 12.74M | 12.7M | 13.07M | 16.25M | 18.87M | 18.91M | 15.51M | 15.26M | 15.09M | 15.02M | 17.87M | 17.08M | 16.3M | 15.64M | 14.32M | 12.74M | 11.26M |
Add to Watchlist
Select watchlists to add or remove ASND